141 reported events
Top reactions: Injection site swelling (29) · Joint swelling (21) · Lameness (21) · Urticaria (20) · Depression (15)
6 authorised products across national registers.
Canada — Health Canada DPD
No residue limits (MRL) are recorded for this substance.
No antimicrobial-resistance surveillance is recorded for this substance.
Spontaneous adverse-event reports that name Glycosaminoglycan Polysulfate, by species — reported counts, not proven reactions.
Top reactions: Injection site swelling (29) · Joint swelling (21) · Lameness (21) · Urticaria (20) · Depression (15)
Source: openFDA Animal & Veterinary adverse-event reports.
Reading about Glycosaminoglycan Polysulfate? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.
Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.